VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 188 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,095,030 | -31.9% | 1,179,255 | +3.9% | 0.00% | 0.0% |
| Q2 2023 | $7,479,153 | +1.8% | 1,134,924 | +4.8% | 0.00% | 0.0% |
| Q1 2023 | $7,350,390 | +94402.3% | 1,082,531 | +2.8% | 0.00% | 0.0% |
| Q4 2022 | $7,778 | -99.9% | 1,052,590 | +2.5% | 0.00% | -50.0% |
| Q3 2022 | $10,141,000 | -8.5% | 1,026,513 | +0.9% | 0.00% | 0.0% |
| Q2 2022 | $11,087,000 | -3.2% | 1,017,168 | +0.5% | 0.00% | +100.0% |
| Q1 2022 | $11,450,000 | -29.0% | 1,012,441 | -1.4% | 0.00% | -50.0% |
| Q4 2021 | $16,117,000 | -7.0% | 1,027,258 | +1.6% | 0.00% | 0.0% |
| Q3 2021 | $17,323,000 | -19.8% | 1,010,704 | +0.6% | 0.00% | -33.3% |
| Q2 2021 | $21,603,000 | +49.0% | 1,004,362 | +4.0% | 0.00% | +50.0% |
| Q1 2021 | $14,500,000 | +29.6% | 965,414 | +13.4% | 0.00% | 0.0% |
| Q4 2020 | $11,187,000 | +41.6% | 851,423 | +4.1% | 0.00% | 0.0% |
| Q3 2020 | $7,900,000 | -14.3% | 817,842 | +1.5% | 0.00% | 0.0% |
| Q2 2020 | $9,219,000 | +16.8% | 805,918 | +5.7% | 0.00% | 0.0% |
| Q1 2020 | $7,896,000 | -68.4% | 762,225 | -49.9% | 0.00% | -33.3% |
| Q4 2019 | $24,960,000 | +148.2% | 1,521,124 | +100.9% | 0.00% | +50.0% |
| Q3 2019 | $10,055,000 | -2.0% | 757,239 | +4.0% | 0.00% | 0.0% |
| Q2 2019 | $10,255,000 | -12.8% | 727,885 | +13.9% | 0.00% | -33.3% |
| Q1 2019 | $11,759,000 | -62.3% | 639,094 | -46.4% | 0.00% | -40.0% |
| Q4 2018 | $31,176,000 | +130.3% | 1,193,252 | +102.3% | 0.01% | +25.0% |
| Q3 2018 | $13,539,000 | +25.8% | 589,960 | +4.4% | 0.00% | +33.3% |
| Q2 2018 | $10,761,000 | +27.5% | 564,920 | +12.7% | 0.00% | 0.0% |
| Q1 2018 | $8,443,000 | +39.2% | 501,146 | +25.6% | 0.00% | +50.0% |
| Q4 2017 | $6,065,000 | -20.5% | 399,046 | -6.3% | 0.00% | -33.3% |
| Q3 2017 | $7,625,000 | +8.3% | 426,044 | -1.4% | 0.00% | 0.0% |
| Q2 2017 | $7,042,000 | +21.9% | 432,054 | +4.7% | 0.00% | +50.0% |
| Q1 2017 | $5,775,000 | -6.8% | 412,524 | +6.2% | 0.00% | -33.3% |
| Q4 2016 | $6,197,000 | +0.0% | 388,583 | +4.4% | 0.00% | 0.0% |
| Q3 2016 | $6,195,000 | +50.6% | 372,309 | +1.3% | 0.00% | +50.0% |
| Q2 2016 | $4,114,000 | +29.7% | 367,657 | -3.2% | 0.00% | 0.0% |
| Q1 2016 | $3,173,000 | -2.0% | 379,671 | +9.2% | 0.00% | 0.0% |
| Q4 2015 | $3,237,000 | +2.0% | 347,732 | +23.5% | 0.00% | 0.0% |
| Q3 2015 | $3,174,000 | -15.4% | 281,471 | -4.8% | 0.00% | 0.0% |
| Q2 2015 | $3,750,000 | +80.0% | 295,545 | +31.9% | 0.00% | +100.0% |
| Q1 2015 | $2,083,000 | -34.2% | 224,072 | +1.3% | 0.00% | -50.0% |
| Q4 2014 | $3,166,000 | +57.4% | 221,105 | +14.1% | 0.00% | +100.0% |
| Q3 2014 | $2,011,000 | -35.1% | 193,740 | +1.2% | 0.00% | -50.0% |
| Q2 2014 | $3,098,000 | +0.4% | 191,492 | +0.8% | 0.00% | 0.0% |
| Q1 2014 | $3,086,000 | +34.6% | 189,929 | +2.8% | 0.00% | 0.0% |
| Q4 2013 | $2,293,000 | +16.1% | 184,816 | +2.6% | 0.00% | 0.0% |
| Q3 2013 | $1,975,000 | +41.6% | 180,065 | +4.3% | 0.00% | +100.0% |
| Q2 2013 | $1,395,000 | – | 172,703 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
| Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
| Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
| Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
| WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
| Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
| Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |